アワード
2021年度 受賞者
Annals of Oncology賞 | ||
---|---|---|
氏名 | ご所属 | 対象論文 |
原谷 浩司 | 近畿大学医学部 腫瘍内科 |
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment https://doi.org/10.1093/annonc/mdx183 |
奨励賞 | ||
氏名 | ご所属 | 演題名 |
足立 雄太 | 愛知県がんセンター研究所 がん標的治療トランスレーショナルリサーチ分野 |
EMT is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C mutant NSCLC |
伊藤 卓彦 | 国立がん研究センター中央病院 | Predictive role of tumor location in 1st-line treatment of colorectal cancer: a multicenter retrospective study of JSCCR |
坂田 能彦 | 済生会熊本病院 呼吸器内科 |
OSImertinib For Advanced non-small cell lung Cancer as first-line Treatment in real world setting (OSI-FACT) |
鈴木 章浩 | 横浜市立大学附属病院 肝胆膵消化器病学 |
Defined Lifestyle and Germline Factors Predispose Asian Populations to Gastric Cancer |
平林 茂樹 | 京都大学 血液・腫瘍内科 |
Impact of pre-transplant minimal residual disease on clinical outcome of unrelated HSCT in patients with Ph+ ALL |
森田 侑香 | がん・感染症センター都立駒込病院 腫瘍内科 |
Impact of pegfilgrastim on relative dose intensity and outcomes of R-CHOP for diffuse large B-cell lymphoma |
Ahmed Abdelsalam | Associate consultant of pediatric oncology at Children's Cancer Hospital Egypt (CCHE 57357). | Outcome of Unilateral Retinoblastoma: A 10- years Experience at Children’s Cancer Hospital in Egypt ( CCHE ) |
Gunn Huh | Department of Internal Medicine, Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine | Gemcitabine plus nab-paclitaxel for second-line therapy of pancreatic cancer: a phase II, single-arm, multicenter study |
Nutthaporn Chandeying | Gynecologic oncology unit, Department of obstetric and gynecology , Faculty of Medicine Vajira Hospital, Navamindradhiraj University | Comparison of psychological, exercise, and music treatments for children and adolescence with cancer: A Meta-analysis |
Jessa Gilda Pandy(※) | Section of Medical Oncology, St. Luke's Medical Center | Risk Factors and Clinical Outcomes of Systemic Cancer Treatment Delay among Cancer patients during the COVID-19 Pandemic |
Timotius Hariyanto(※) | Faculty of Medicine, Pelita Harapan University | The Impact of Chemotherapy for Cancer Patients With COVID-19 on Severity and Mortality Outcomes: A Meta-Analysis |
(※)COVID-19特別枠での受賞です
(敬称略・登録番号順)
※ご所属は受賞当時のものを掲載しております。
●授賞の様子
(JSMO2021は新型コロナウイルス感染拡大の影響によりバーチャル開催となったため、表彰式は開催されておりません。)
※クリックすると大きな画像でご覧いただけます。